about
Synergistic antileukemic interactions between 2-medroxyestradiol (2-ME) and histone deacetylase inhibitors involve Akt down-regulation and oxidative stressLocation-specific epigenetic regulation of the metallothionein 3 gene in esophageal adenocarcinomas.Simultaneous quantitative and allele-specific expression analysis with real competitive PCRChemoprevention of Breast Cancer by Dietary PolyphenolsTowards an understanding of the role of DNA methylation in rheumatoid arthritis: therapeutic and diagnostic implicationsTargeting Epigenetic Processes in Photodynamic Therapy-Induced Anticancer ImmunityDysregulated transcriptional and post-translational control of DNA methyltransferases in cancerCombating the epigenome: epigenetic drugs against non-Hodgkin's lymphomaThe genetic and epigenetic alterations in human hepatocellular carcinoma: a recent updateCRD-BP/IMP1 expression characterizes cord blood CD34+ stem cells and affects c-myc and IGF-II expression in MCF-7 cancer cellsThe retinoblastoma gene and its product are targeted by ICBP90: a key mechanism in the G1/S transition during the cell cycleHDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeuticsComputational Analysis and Predictive Cheminformatics Modeling of Small Molecule Inhibitors of Epigenetic ModifiersInactivation of the MAL gene in breast cancer is a common event that predicts benefit from adjuvant chemotherapy.Overexpression of NSUN2 by DNA hypomethylation is associated with metastatic progression in human breast cancer.Assessment of changes in the BRCA2 and P53 genes in breast invasive ductal carcinoma in northeast Brazil.Parvovirus nonstructural proteins induce an epigenetic modification through histone acetylation in host genes and revert tumor malignancy to benignancy.Association between lifestyle factors and CpG island methylation in a cancer-free population.Valproate activates bovine leukemia virus gene expression, triggers apoptosis, and induces leukemia/lymphoma regression in vivo.HDAC inhibitor, valproic acid, induces p53-dependent radiosensitization of colon cancer cells.Human ZNF312b oncogene is regulated by Sp1 binding to its promoter region through DNA demethylation and histone acetylation in gastric cancer.Comparison of the anti-cancer effect of Disulfiram and 5-Aza-CdR on pancreatic cancer cell line PANC-1Combination of sapacitabine and HDAC inhibitors stimulates cell death in AML and other tumour types.PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer.Regulation of CRADD-caspase 2 cascade by histone deacetylase 1 in gastric cancerEpigenetic regulation of multiple tumor-related genes leads to suppression of breast tumorigenesis by dietary genisteinEpigenotoxicity of environmental pollutants evaluated by a combination of DNA methylation inhibition and capillary electrophoresis-laser-induced fluorescence immunoassay.Identification of kazinol Q, a natural product from Formosan plants, as an inhibitor of DNA methyltransferase.Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer propertiesComprehensive DNA methylation analysis of human peripheral blood leukocytes and lymphoblastoid cell linesGenome-wide promoter analysis uncovers portions of the cancer methylome.The role of epigenetics in personalized medicine: challenges and opportunities.Aberrant promoter methylation of the ABCG2 gene in renal carcinomaDeletion of betaine-homocysteine S-methyltransferase in mice perturbs choline and 1-carbon metabolism, resulting in fatty liver and hepatocellular carcinomasEpigenetic Contributions to the Relationship between Cancer and Dietary Intake of Nutrients, Bioactive Food Components, and Environmental Toxicants.Association between serum folate level and cervical cancer: a meta-analysis.TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer.The Role of Dietary Extra Virgin Olive Oil and Corn Oil on the Alteration of Epigenetic Patterns in the Rat DMBA-Induced Breast Cancer ModelDickkopf-1 is an epigenetically silenced candidate tumor suppressor gene in medulloblastomaCancer epigenetics: above and beyond
P2860
Q23918915-EF9A0F0E-2BFA-4FDA-A8D8-C8EC151D7F65Q24319083-4110661A-4A04-4F93-A826-BC3AFBF7ECF8Q24798878-2B531D03-E68F-4EE9-AA20-A17A5225FF09Q26773449-0C008C34-538A-46CF-B2B5-9617BCA51567Q26783490-4633E059-6336-421B-AE71-CEE448D2785CQ26797280-39127D34-D0C6-4442-8F82-AADD57DC3D47Q26827297-94921E03-0FB8-4D69-93D4-6065A8F42265Q26851166-26B21E80-4E4B-441E-8147-76FA278BCF7FQ27003050-5FBD877F-DC5C-4683-8239-754A67736B3EQ28239956-4986E22C-9D86-4DD0-8B8F-02DBBEA8BEFEQ28260808-83E30867-3CE6-42FD-971C-551E4750F529Q28290352-526717D1-AB32-4685-9231-1980DA067CB2Q28554035-3AC4C56F-CF4F-4C5F-B246-B5BBB4E748A1Q33408105-C01EC7BD-A49F-4802-9299-7014ABA9B1F2Q33591335-B0562C09-FC6F-417B-BAF0-4132B670DEA4Q33766324-7D392D71-DB41-47DD-998D-3F3931E11045Q33884051-660CFF67-69C7-49A4-8FD7-010FAFFF5EB4Q33886934-009E0487-A49D-46EE-B3D2-B66860A08102Q33900608-D84C5365-630B-4D26-A645-4D6F5E34BCCEQ34062580-97D121DC-15EE-4BCD-B88C-074C074394B8Q34155688-E75C03E8-CE91-450A-9977-645CC3E9A024Q34170221-23F3A385-C041-4877-A0D2-94F7131AF017Q34344158-ED25C0F8-94EA-47E1-8126-A5F7066CB36FQ34351507-22218002-D6D6-435B-B70B-C1CCBACBBE8BQ34420590-2A894C53-C77A-4B09-B8C7-CE7F4B4EDB5AQ34559384-67563285-3E2D-40C0-A889-AD1600797AFBQ34573062-F162FEC5-7F7E-4DC9-9BF5-43FA1FA1E8A4Q34601752-92489779-D350-4F82-A8EB-602A69D2477EQ34989248-EA0E82B5-A3E3-4E53-AA58-7FD13BDF5034Q35001966-DCAF5DC0-088F-47AF-A4E3-4C2FF9FBDDF9Q35008027-3D63FDDD-D374-42EA-9DF8-10D4609284BBQ35043066-D799E00A-37E3-4C5F-8C5D-5A0722B4F17EQ35131563-160C8E76-AF8A-4EB0-A996-5A481647C101Q35379075-0C3AFB35-5530-458A-96B6-262F57BD098BQ35697918-76C083A8-2904-4533-BF55-E42BF6758445Q35759528-6F878123-8CAE-4E56-BC44-601A6B03F1D1Q35768799-413AA74E-C9FF-4C6B-94DC-CE319A1AFC4FQ35786332-B0F85386-EE35-4DBD-BF65-FA7379E94369Q35799986-824D0EF3-7FE0-4AC8-A49B-88CFE7DFB3A6Q35844494-4E37AE7D-18C7-4268-B007-7E52ABF38A51
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cancer epigenetics.
@ast
Cancer epigenetics.
@en
type
label
Cancer epigenetics.
@ast
Cancer epigenetics.
@en
prefLabel
Cancer epigenetics.
@ast
Cancer epigenetics.
@en
P2860
P356
P1433
P1476
Cancer epigenetics.
@en
P2093
Richard L Momparler
P2860
P2888
P304
P356
10.1038/SJ.ONC.1206774
P407
P577
2003-09-01T00:00:00Z
P5875
P6179
1031013098